Atorvastatin Reduces Circulating S100A12 Levels in Patients with Carotid Atherosclerotic Plaques - A Link with Plaque Inflammation
CONCLUSIONS: Atorvastatin treatment reduced S100A12/CRP levels, and the changes in these circulating markers mirrored the improvement in arterial inflammation. Our observations suggest that S100A12 may be an emerging therapeutic target for atherosclerosis.PMID:33952812 | DOI:10.5551/jat.61630
Source: Journal of Atherosclerosis and Thrombosis - Category: Cardiology Authors: Tomohiro Komatsu Makoto Ayaori Harumi Uto-Kondo Katsumi Hayashi Katsumi Tamura Hiroki Sato Makoto Sasaki Takafumi Nishida Shunichi Takiguchi Emi Yakushiji Kazuhiro Nakaya Katsunori Ikewaki Source Type: research
More News: Atorvastatin Calcium | Cardiology | Cardiovascular | Cholesterol | CT Scan | Diets | Heart | Lipitor | Nutrition | PET Scan | Statin Therapy | Study | Thrombosis | Zivast